InDex Pharmaceuticals Holding AB(SE:FLERIE)
kr 13.000.00 (0.00%)
SE:FLERIE
InDex Pharmaceuticals Holding AB financials statements
kr 13.00
At close:0.00 (0.00%)
Want to see SE:FLERIE full AI Analyst Report?
InDex Pharmaceuticals Holding AB (FLERIE) Ratios
2 Followers
InDex Pharmaceuticals Holding AB Ratios
SE:FLERIE's free cash flow for Q3 2026 was kr500.00K. For the 2026 fiscal year, SE:FLERIE's free cash flow was increased by kr0.00 and operating cash flow was kr500.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 52.31 | 55.39 | 5.04 | 23.57 | 41.93 |
| Quick Ratio | 52.31 | 55.39 | 5.04 | 23.57 | 41.93 |
| Cash Ratio | 38.86 | 46.76 | 5.00 | 23.41 | 40.55 |
| Solvency Ratio | -37.26 | -8.99 | -1.55 | -5.71 | -9.12 |
| Operating Cash Flow Ratio | -2.02 | -0.92 | -0.64 | -8.78 | -11.74 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -42.50 | 0.00 | 0.00 | 20676.33 |
| Net Current Asset Value | kr 706.80M | kr 999.40M | kr 236.11M | kr 329.97M | kr 431.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.01 | 1.01 | 1.25 | 1.05 | 1.03 |
| Debt Service Coverage Ratio | -54.20 | -53.81 | -413.31 | -826.23 | -800.46 |
| Interest Coverage Ratio | -57.09 | -29.16 | -472.98 | -1259.28 | -869.40 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Interest Debt Per Share | 0.20 | 0.07 | 0.05 | 0.06 | 0.03 |
| Net Debt to EBITDA | 0.72 | 3.83 | 3.11 | 3.45 | 4.20 |
| Profitability Margins | |||||
| Gross Profit Margin | -144.32% | -41600.00% | 95.74% | 0.00% | 0.00% |
| EBIT Margin | -8456.82% | -226500.00% | -97.47% | 0.00% | 0.00% |
| EBITDA Margin | -8450.00% | -225900.00% | -96.22% | 0.00% | 0.00% |
| Operating Profit Margin | -8887.50% | -110800.00% | -110.11% | 0.00% | 0.00% |
| Pretax Profit Margin | -8612.50% | -227900.00% | -97.70% | 0.00% | 0.00% |
| Net Profit Margin | -8601.14% | -228000.00% | -97.70% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -8601.14% | -228000.00% | -97.70% | 0.00% | 0.00% |
| Net Income Per EBT | 99.87% | 100.04% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.91% | 205.69% | 88.73% | 66.40% | 89.11% |
| Return on Assets (ROA) | -22.28% | -5.40% | -31.82% | -28.56% | -23.15% |
| Return on Equity (ROE) | -22.41% | -5.43% | -39.88% | -30.04% | -23.74% |
| Return on Capital Employed (ROCE) | -23.12% | -2.64% | -44.65% | -44.89% | -26.60% |
| Return on Invested Capital (ROIC) | -23.08% | -2.63% | -44.52% | -44.81% | -26.56% |
| Return on Tangible Assets | -22.28% | -5.40% | -31.82% | -28.56% | -23.15% |
| Earnings Yield | -29.63% | -7.88% | -3.32% | -3.50% | -3.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.04 | 0.00 | 42.52 | 0.00 | 0.00 |
| Payables Turnover | 15.36 | 69.50 | 0.62 | 0.16 | 0.28 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 5.18 | 0.10 | 35.16 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.33 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.01 | 0.00 | 0.34 | 0.00 | 0.00 |
| Cash Conversion Cycle | 9441.35 | 539099.75 | -583.42 | -2246.50 | -1311.03 |
| Days of Sales Outstanding | 9465.11 | 539105.00 | 8.58 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 23.77 | 5.25 | 592.01 | 2246.50 | 1311.03 |
| Operating Cycle | 9465.11 | 539105.00 | 8.58 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.36 | -0.24 | -0.71 | -2.43 | -2.57 |
| Free Cash Flow Per Share | -0.36 | -0.24 | -0.71 | -2.43 | -2.57 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -13.38 | -21.25 | -16.53 | -39.80 | -96.77 |
| Operating Cash Flow to Sales Ratio | -3.19 | -170.00 | -0.39 | 0.00 | 0.00 |
| Free Cash Flow Yield | -1.10% | -0.59% | -1.33% | -4.52% | -4.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.37 | -12.68 | -30.08 | -28.56 | -25.24 |
| Price-to-Sales (P/S) Ratio | 290.28 | 28949.51 | 29.39 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.76 | 0.69 | 12.00 | 8.58 | 5.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -90.91 | -170.29 | -75.46 | -22.14 | -20.96 |
| Price-to-Operating Cash Flow Ratio | -90.91 | -170.29 | -75.46 | -22.14 | -20.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 0.15 | 5.90 | 2.46 | 2.09 |
| Enterprise Value Multiple | -2.71 | -8.99 | -27.43 | -25.46 | -21.38 |
| Enterprise Value | 2.02B | 2.03B | 2.57B | 2.52B | 2.17B |
| EV to EBITDA | -2.71 | -8.99 | -27.43 | -25.46 | -21.38 |
| EV to Sales | 229.13 | 20306.51 | 26.40 | 0.00 | 0.00 |
| EV to Free Cash Flow | -71.76 | -119.45 | -67.78 | -19.50 | -17.52 |
| EV to Operating Cash Flow | -71.76 | -119.45 | -67.78 | -19.50 | -17.52 |
| Tangible Book Value Per Share | 43.32 | 59.57 | 4.48 | 6.27 | 8.98 |
| Shareholders’ Equity Per Share | 43.32 | 59.57 | 4.48 | 6.27 | 8.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.11 | 0.00 | 1.83 | 0.00 | 0.00 |
| Net Income Per Share | -9.71 | -3.24 | -1.79 | -1.88 | -2.13 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 69.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.04 | 0.07 | 0.40 | 1.29 | 1.20 |
Currency in SEK

